Hypoxia inducible factors 1α and 2α are associated with VEGF expression and angiogenesis in gallbladder carcinomas

Journal of Surgical Oncology

Volumn 94, Issue 3, 2006, Pages 242-247

  Giatromanolaki, A ^a   Sivridis, E ^a   Simopoulos, C ^a   Polychronidis, A ^a   Gatter, K C ^b   Harris, A L ^b   Koukourakis, M I ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Gallbladder adenocarcinoma; HIF 1 ; HIF 2 ; Prognosis; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ADENOCARCINOMA; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; UPREGULATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33747873394     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20443     Document Type: Article

References (35)

1. Maxwell PH, Dachs GU, Gleadle JM, et al.: Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 1997;94:8104-8109.
2. Forsythe JA, Jiang BH, Iyer NV, et al.: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-4613.
3. Takeda N, Maemura K, Imai Y, et al.: Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996;271:32529-32537.
4. Semenza GL: Regulation of erythropoietin production. New insights into molecular mechanisms of oxygen homeostasis. Hematol Oncol Clin North Am 1994;8:863-884.
5. Huang LE, Arany Z, Livingston DM, et al.: Activation of Hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its a subunit. J Biol Chem 1996;271:32253-32259.
6. Huang LE, Gu J, Scheau M, et al.: Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitine-proteasome pathway. Proc Natl Acad Sci USA 1998;95:7987-7992.
7. Mazure NM, Chen EY, Laderoute KR, et al.: Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 1999;90:3322-3331.
8. Zundel W, Schindler C, Haas-Kogan D, et al.: Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000;14:391-396.
9. Laughner E, Taghavi P, Chiles K, et al.: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001;21:3995-4004.
10. Wiesener MS, Turley H, Allen WE, et al.: Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1 alpha. Blood 1998;92:2260-2268.
11. Zhi YH, Liu RS, Song MM, et al.: Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. World J Gastroenterol 2005;11:3724-3728.
12. Yamamoto S, Fujii K, Kitadai Y, et al.: Expression of vascular endothelial growth factor in human gallbladder lesions. Oncol Rep 1998;5:1065-1069.
13. Giatromanolaki A, Koukourakis MI, Simopoulos C, et al.: Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas. Eur J Surg Oncol 2003;29:879-883.
14. Nakashima T, Kondoh S, Kitoh H, et al.: Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis. Int J Mol Med 2003;11:33-39.
15. Yue SQ, Yang YL, Zhou JS, et al.: Relationship between urokinase-type plasminogen activator receptor and vascular endothelial growth factor expression and metastasis of gallbladder cancer. World J Gastroenterol 2004;10:2750-2752.
16. Okita S, Kondoh S, Shiraishi K, et al.: Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer. Int J Oncol 1998;12:1013-1018.
17. Giatromanolaki A, Harris AL: Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res 2001;21:4317-4324.
18. Zhong H, De Marzo AM, Laughner E, et al.: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999;59:5830-5835.
19. Talks KL, Turley H, Gatter KC, et al: The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000;157:411-421.
20. Giatromanolaki A, Koukourakis MI, Sivridis E, et al.: Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 2001;85:881-890.
21. Giatromanolaki A, Sivridis E, Simopoulos C, et al.: Thymidine phosphorylase expression in gallbladder adenocarcinomas. Int J Surg Pathol 2002;10:181-188.
22. Giatromanolaki A, Sivridis E, Koukourakis MI, et al.: Prognostic role of angiogenesis in operable carcinoma of the gallbladder. Am J Clin Oncol 2002;25:38-41.
23. Turley H, Scott PA, Watts VM, et al.: Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol 1998;186:313-318.
24. Giatromanolaki A, Sivridis E, Koukourakis MI: Tumour angiogenesis: Vascular growth and survival. APMIS 2004;112:431-440.
25. Quan ZW, Wu K, Wang J, et al.: Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer. J Am Coll Surg 2001;193:380-383.
26. Takeda N, Maemura K, Imai Y, et al.: Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Fit-1. Circ Res 2004;95:146-153.
27. Elvert G, Kappel A, Heidenreich R, et al.: Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 2003;278:7520-7530.
28. Brown NS, Jones A, Fujiyama C, et al.: Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res 2000;60:6298-6302.
29. Sivridis E, Giatromanolaki A, Gatter KC, et al.: Tumor and Angiogenesis Research Group. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 2002;95:1055-1063.
30. Koukourakis MI, Giatromanolaki A, Sivridis E, et al.: Hypoxia-inducible factor (HIF-1α and HIF-2α), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;53:1192-1202.
31. Giatromanolaki A, Sivridis E, Kouskoukis C, et al.: Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res 2003;13:493-501.
32. Lu H, Forbes RA, Verma A: Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 2003;277, 23111-23115.
33. Kothari S, Cizeau J, McMillan-Ward E, et al.: BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003;22:4734-4744.
34. Sowter HM, Ratcliffe PJ, Watson P, et al.: HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001;61:6669-6673.
35. Welsh SJ, Powis G: Hypoxia inducible factor as a cancer drug target. Curr Cancer Drug Targets 2003;3:391-405.